A Prospective Study to Assess the Feasibility of Axillary Reverse Mapping and Evaluate Its Effect on Preventing Lymphedema in Breast Cancer Patients.
Identifieur interne : 000F85 ( PubMed/Corpus ); précédent : 000F84; suivant : 000F86A Prospective Study to Assess the Feasibility of Axillary Reverse Mapping and Evaluate Its Effect on Preventing Lymphedema in Breast Cancer Patients.
Auteurs : Tao Yue ; Dayong Zhuang ; Peng Zhou ; Luming Zheng ; Ziyi Fan ; Jian Zhu ; Lei Hou ; Fang Yu ; Xuefeng Dong ; Lei Xiao ; Qingqing HeSource :
- Clinical breast cancer [ 1938-0666 ] ; 2015.
English descriptors
- KwdEn :
- Adult, Aged, Axilla (diagnostic imaging), Breast Neoplasms (pathology), Carcinoma, Ductal, Breast (pathology), Coloring Agents, Female, Humans, Lymph Node Excision (adverse effects), Lymph Node Excision (methods), Lymphatic Metastasis (pathology), Lymphatic Vessels (diagnostic imaging), Lymphedema (prevention & control), Methylene Blue, Middle Aged, Prospective Studies, Radioactive Tracers, Radionuclide Imaging.
- MESH :
- chemical : Coloring Agents, Methylene Blue, Radioactive Tracers.
- adverse effects : Lymph Node Excision.
- diagnostic imaging : Axilla, Lymphatic Vessels.
- methods : Lymph Node Excision.
- pathology : Breast Neoplasms, Carcinoma, Ductal, Breast, Lymphatic Metastasis.
- prevention & control : Lymphedema.
- Adult, Aged, Female, Humans, Middle Aged, Prospective Studies, Radionuclide Imaging.
Abstract
The axillary reverse mapping (ARM) procedure can distinguish lymphatics draining the arm from those draining the breast. It has been proposed to preserve lymphatic drainage of the upper limbs and reduce the incidence of upper limb lymphedema during breast cancer surgery. The aim of our study was to assess the feasibility of ARM in modified radical mastectomy and to evaluate its effect on prevention of lymphedema.
DOI: 10.1016/j.clbc.2015.01.010
PubMed: 25776198
Links to Exploration step
pubmed:25776198Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A Prospective Study to Assess the Feasibility of Axillary Reverse Mapping and Evaluate Its Effect on Preventing Lymphedema in Breast Cancer Patients.</title><author><name sortKey="Yue, Tao" sort="Yue, Tao" uniqKey="Yue T" first="Tao" last="Yue">Tao Yue</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Zhuang, Dayong" sort="Zhuang, Dayong" uniqKey="Zhuang D" first="Dayong" last="Zhuang">Dayong Zhuang</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Zhou, Peng" sort="Zhou, Peng" uniqKey="Zhou P" first="Peng" last="Zhou">Peng Zhou</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Zheng, Luming" sort="Zheng, Luming" uniqKey="Zheng L" first="Luming" last="Zheng">Luming Zheng</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Fan, Ziyi" sort="Fan, Ziyi" uniqKey="Fan Z" first="Ziyi" last="Fan">Ziyi Fan</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Zhu, Jian" sort="Zhu, Jian" uniqKey="Zhu J" first="Jian" last="Zhu">Jian Zhu</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Hou, Lei" sort="Hou, Lei" uniqKey="Hou L" first="Lei" last="Hou">Lei Hou</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Yu, Fang" sort="Yu, Fang" uniqKey="Yu F" first="Fang" last="Yu">Fang Yu</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Dong, Xuefeng" sort="Dong, Xuefeng" uniqKey="Dong X" first="Xuefeng" last="Dong">Xuefeng Dong</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Xiao, Lei" sort="Xiao, Lei" uniqKey="Xiao L" first="Lei" last="Xiao">Lei Xiao</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="He, Qingqing" sort="He, Qingqing" uniqKey="He Q" first="Qingqing" last="He">Qingqing He</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China. Electronic address: heqingqing@yeah.net.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25776198</idno><idno type="pmid">25776198</idno><idno type="doi">10.1016/j.clbc.2015.01.010</idno><idno type="wicri:Area/PubMed/Corpus">000F85</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F85</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A Prospective Study to Assess the Feasibility of Axillary Reverse Mapping and Evaluate Its Effect on Preventing Lymphedema in Breast Cancer Patients.</title><author><name sortKey="Yue, Tao" sort="Yue, Tao" uniqKey="Yue T" first="Tao" last="Yue">Tao Yue</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Zhuang, Dayong" sort="Zhuang, Dayong" uniqKey="Zhuang D" first="Dayong" last="Zhuang">Dayong Zhuang</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Zhou, Peng" sort="Zhou, Peng" uniqKey="Zhou P" first="Peng" last="Zhou">Peng Zhou</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Zheng, Luming" sort="Zheng, Luming" uniqKey="Zheng L" first="Luming" last="Zheng">Luming Zheng</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Fan, Ziyi" sort="Fan, Ziyi" uniqKey="Fan Z" first="Ziyi" last="Fan">Ziyi Fan</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Zhu, Jian" sort="Zhu, Jian" uniqKey="Zhu J" first="Jian" last="Zhu">Jian Zhu</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Hou, Lei" sort="Hou, Lei" uniqKey="Hou L" first="Lei" last="Hou">Lei Hou</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Yu, Fang" sort="Yu, Fang" uniqKey="Yu F" first="Fang" last="Yu">Fang Yu</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Dong, Xuefeng" sort="Dong, Xuefeng" uniqKey="Dong X" first="Xuefeng" last="Dong">Xuefeng Dong</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Xiao, Lei" sort="Xiao, Lei" uniqKey="Xiao L" first="Lei" last="Xiao">Lei Xiao</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="He, Qingqing" sort="He, Qingqing" uniqKey="He Q" first="Qingqing" last="He">Qingqing He</name><affiliation><nlm:affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China. Electronic address: heqingqing@yeah.net.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Clinical breast cancer</title><idno type="eISSN">1938-0666</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Axilla (diagnostic imaging)</term><term>Breast Neoplasms (pathology)</term><term>Carcinoma, Ductal, Breast (pathology)</term><term>Coloring Agents</term><term>Female</term><term>Humans</term><term>Lymph Node Excision (adverse effects)</term><term>Lymph Node Excision (methods)</term><term>Lymphatic Metastasis (pathology)</term><term>Lymphatic Vessels (diagnostic imaging)</term><term>Lymphedema (prevention & control)</term><term>Methylene Blue</term><term>Middle Aged</term><term>Prospective Studies</term><term>Radioactive Tracers</term><term>Radionuclide Imaging</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Coloring Agents</term><term>Methylene Blue</term><term>Radioactive Tracers</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Axilla</term><term>Lymphatic Vessels</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term><term>Carcinoma, Ductal, Breast</term><term>Lymphatic Metastasis</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Prospective Studies</term><term>Radionuclide Imaging</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The axillary reverse mapping (ARM) procedure can distinguish lymphatics draining the arm from those draining the breast. It has been proposed to preserve lymphatic drainage of the upper limbs and reduce the incidence of upper limb lymphedema during breast cancer surgery. The aim of our study was to assess the feasibility of ARM in modified radical mastectomy and to evaluate its effect on prevention of lymphedema.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25776198</PMID><DateCreated><Year>2015</Year><Month>07</Month><Day>13</Day></DateCreated><DateCompleted><Year>2016</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1938-0666</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Clinical breast cancer</Title><ISOAbbreviation>Clin. Breast Cancer</ISOAbbreviation></Journal><ArticleTitle>A Prospective Study to Assess the Feasibility of Axillary Reverse Mapping and Evaluate Its Effect on Preventing Lymphedema in Breast Cancer Patients.</ArticleTitle><Pagination><MedlinePgn>301-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clbc.2015.01.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1526-8209(15)00028-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The axillary reverse mapping (ARM) procedure can distinguish lymphatics draining the arm from those draining the breast. It has been proposed to preserve lymphatic drainage of the upper limbs and reduce the incidence of upper limb lymphedema during breast cancer surgery. The aim of our study was to assess the feasibility of ARM in modified radical mastectomy and to evaluate its effect on prevention of lymphedema.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">From January 2012 to March 2014, a prospective study was performed in 265 breast cancer patients who underwent modified radical mastectomy. Patients were divided into 2 groups, 127 patients (47.93%, control group) received a traditional axillary lymph node dissection (ALND), and 138 patients (52.07%, experimental group) received ARM preservation of the nodes and lymphatics during ALND. Radioactive tracer and methylene blue were used for ARM of the nodes and lymphatics. All of the identified ARM nodes were diagnosed using fine needle aspiration cytology for assessment of metastatic status. All resected axillary lymph nodes were conducted in a pathology examination to evaluate tumor metastasis. Data were collected on variations in identification of the ARM nodes and lymphatics, the metastasis of ARM nodes, and the occurrence of lymphedema.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the experimental group, the ARM procedure was successfully conducted in 129 cases (93.48%). ARM nodes metastasis occurred in 11 patients (8.53%). The median follow-up time was 20 months, at the last evaluation there were 42 patients who developed upper limb lymphedema in the control group (33.07%), and in the experimental group the incidence of lymphedema was 5.93% (7/118; P < .001). None of the patients had nodal relapses during the follow-up time.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">ARM appears to be a feasible technique with which to identify upper arm nodes and lymphatics during the modified radical mastectomy procedure. The incidence of lymphedema can be decreased in patients with use of the ARM procedure.</AbstractText><CopyrightInformation>Copyright © 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yue</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhuang</LastName><ForeName>Dayong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Luming</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Ziyi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Xuefeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Qingqing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, Jinan, People's Republic of China. Electronic address: heqingqing@yeah.net.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Breast Cancer</MedlineTA><NlmUniqueID>100898731</NlmUniqueID><ISSNLinking>1526-8209</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004396">Coloring Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011849">Radioactive Tracers</NameOfSubstance></Chemical><Chemical><RegistryNumber>T42P99266K</RegistryNumber><NameOfSubstance UI="D008751">Methylene Blue</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001365" MajorTopicYN="N">Axilla</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018270" MajorTopicYN="N">Carcinoma, Ductal, Breast</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004396" MajorTopicYN="N">Coloring Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042601" MajorTopicYN="N">Lymphatic Vessels</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008751" MajorTopicYN="N">Methylene Blue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011849" MajorTopicYN="N">Radioactive Tracers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011877" MajorTopicYN="N">Radionuclide Imaging</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Axillary lymph node dissection</Keyword><Keyword MajorTopicYN="N">Lymphoscintigraphy</Keyword><Keyword MajorTopicYN="N">Methylene blue</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword><Keyword MajorTopicYN="N">Upper limb lymphedema</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>01</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25776198</ArticleId><ArticleId IdType="pii">S1526-8209(15)00028-2</ArticleId><ArticleId IdType="doi">10.1016/j.clbc.2015.01.010</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F85 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000F85 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:25776198
|texte= A Prospective Study to Assess the Feasibility of Axillary Reverse Mapping and Evaluate Its Effect on Preventing Lymphedema in Breast Cancer Patients.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:25776198" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |